scholarly article | Q13442814 |
P2093 | author name string | Peggy L Kendall | |
Rachel A Henry | |||
P2860 | cites work | B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue | Q24669900 |
A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice | Q34035323 | ||
Vkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains | Q34267403 | ||
Activation of Rheumatoid Factor (RF) B Cells and Somatic Hypermutation Outside of Germinal Centers in Autoimmune‐Prone MRL/lpr Mice | Q35119889 | ||
Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor | Q36369174 | ||
A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice | Q36369177 | ||
Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites | Q42206660 | ||
Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand 13-producing stromal network in chronic lesions of autoimmune gastritis. | Q42451126 | ||
Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes | Q42617543 | ||
Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice | Q42661803 | ||
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome | Q60810881 | ||
Systematic microanatomical analysis of CXCL13 and CCL21in situ production and progressive lymphoid organization in rheumatoid synovitis | Q60810884 | ||
Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study | Q67298313 | ||
Lymphoid neogenesis in rheumatoid synovitis | Q74147962 | ||
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice | Q77136854 | ||
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome | Q77179303 | ||
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint | Q79765411 | ||
Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure | Q80171529 | ||
Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice | Q80442791 | ||
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lymphocyte | Q715347 |
bias | Q742736 | ||
tertiary lymphoid structure | Q54928327 | ||
P304 | page(s) | 1460-1465 | |
P577 | publication date | 2010-06-23 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice | |
P478 | volume | 185 |
Q50882786 | A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. |
Q55038717 | A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression. |
Q99711793 | Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective? |
Q37238275 | CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis |
Q91596260 | Circulating CXCR5-PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes |
Q26799117 | Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment |
Q28071695 | Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon |
Q40557011 | Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection |
Q26778348 | Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues |
Q38221815 | Ectopic lymphoid-like structures in infection, cancer and autoimmunity |
Q38091729 | Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease |
Q38939468 | IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung |
Q26742160 | Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung |
Q37469720 | Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells |
Q42128925 | Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient mice |
Q37729359 | Regulatory B cells in autoimmune diseases |
Q49123591 | Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease |
Q37548717 | Severe clinical presentation of visceral leishmaniasis in naturally infected dogs with disruption of the splenic white pulp. |
Q35597162 | T cell-driven initiation and propagation of autoimmune diabetes |
Q36260514 | Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice |
Q38012568 | Tertiary lymphoid organs in infection and autoimmunity |
Q39201665 | Tertiary lymphoid organs in systemic autoimmune diseases: pathogenic or protective? |
Q26776542 | The Ins and Outs of B Cells in Multiple Sclerosis |
Q35104199 | The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system |
Q38728631 | The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy |
Q36838604 | Tolerant anti-insulin B cells are effective APCs |
Search more.